vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and T1 Energy Inc. (TE). Click either name above to swap in a different company.
T1 Energy Inc. is the larger business by last-quarter revenue ($210.5M vs $207.8M, roughly 1.0× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -62.0%, a 119.4% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $55.0M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.
IDYA vs TE — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $207.8M | $210.5M |
| Net Profit | $119.2M | $-130.6M |
| Gross Margin | — | 10.0% |
| Operating Margin | 52.2% | -45.0% |
| Net Margin | 57.4% | -62.0% |
| Revenue YoY | — | — |
| Net Profit YoY | 330.1% | -375.2% |
| EPS (diluted) | $1.33 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $207.8M | $210.5M | ||
| Q2 25 | — | $132.8M | ||
| Q1 25 | — | $53.5M | ||
| Q3 24 | $0 | $0 | ||
| Q2 24 | $0 | $0 | ||
| Q1 24 | $0 | $0 | ||
| Q3 22 | $29.7M | — |
| Q3 25 | $119.2M | $-130.6M | ||
| Q2 25 | — | $-31.9M | ||
| Q1 25 | — | $-16.2M | ||
| Q3 24 | $-51.8M | $-27.5M | ||
| Q2 24 | $-52.8M | $-27.0M | ||
| Q1 24 | $-39.6M | $-28.5M | ||
| Q3 22 | $1.6M | — |
| Q3 25 | — | 10.0% | ||
| Q2 25 | — | 24.7% | ||
| Q1 25 | — | 33.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | — |
| Q3 25 | 52.2% | -45.0% | ||
| Q2 25 | — | -22.0% | ||
| Q1 25 | — | -44.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 2.2% | — |
| Q3 25 | 57.4% | -62.0% | ||
| Q2 25 | — | -24.0% | ||
| Q1 25 | — | -30.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 5.4% | — |
| Q3 25 | $1.33 | $-0.87 | ||
| Q2 25 | — | $-0.21 | ||
| Q1 25 | — | $-0.11 | ||
| Q3 24 | $-0.60 | $-0.20 | ||
| Q2 24 | $-0.68 | $-0.19 | ||
| Q1 24 | $-0.53 | $-0.20 | ||
| Q3 22 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $34.1M |
| Total DebtLower is stronger | — | $547.3M |
| Stockholders' EquityBook value | $1.1B | $96.9M |
| Total Assets | $1.2B | $1.4B |
| Debt / EquityLower = less leverage | — | 5.65× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $786.9M | $34.1M | ||
| Q2 25 | — | $8.5M | ||
| Q1 25 | — | $48.9M | ||
| Q3 24 | $920.0M | $181.9M | ||
| Q2 24 | $701.7M | $219.6M | ||
| Q1 24 | $698.8M | $249.9M | ||
| Q3 22 | $386.2M | — |
| Q3 25 | — | $547.3M | ||
| Q2 25 | — | $591.2M | ||
| Q1 25 | — | $603.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $602.3M | ||
| Q3 22 | — | — |
| Q3 25 | $1.1B | $96.9M | ||
| Q2 25 | — | $183.9M | ||
| Q1 25 | — | $201.9M | ||
| Q3 24 | $1.2B | $538.7M | ||
| Q2 24 | $931.7M | $561.6M | ||
| Q1 24 | $935.3M | $582.3M | ||
| Q3 22 | $368.8M | — |
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q3 24 | $1.2B | $615.0M | ||
| Q2 24 | $973.7M | $644.4M | ||
| Q1 24 | $961.5M | $670.3M | ||
| Q3 22 | $410.9M | — |
| Q3 25 | — | 5.65× | ||
| Q2 25 | — | 3.21× | ||
| Q1 25 | — | 2.99× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.03× | ||
| Q3 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $63.9M |
| Free Cash FlowOCF − Capex | $142.2M | $55.0M |
| FCF MarginFCF / Revenue | 68.4% | 26.1% |
| Capex IntensityCapex / Revenue | 0.0% | 4.2% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $-42.3M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $142.2M | $63.9M | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $-44.8M | ||
| Q3 24 | $-49.2M | $-28.4M | ||
| Q2 24 | $-32.9M | $-28.0M | ||
| Q1 24 | $-43.8M | $-16.2M | ||
| Q3 22 | $-24.2M | — |
| Q3 25 | $142.2M | $55.0M | ||
| Q2 25 | — | $10.6M | ||
| Q1 25 | — | $-74.0M | ||
| Q3 24 | $-49.7M | $-34.0M | ||
| Q2 24 | $-33.9M | $-35.6M | ||
| Q1 24 | $-45.1M | $-37.7M | ||
| Q3 22 | $-25.3M | — |
| Q3 25 | 68.4% | 26.1% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | -138.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | -85.1% | — |
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 54.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 3.7% | — |
| Q3 25 | 1.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | -14.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |